This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Oracle's (ORCL) Healthcare Expansion to Aid Long-Term Growth
by Zacks Equity Research
Oracle's (ORCL) portfolio of healthcare offerings expands with the latest Oracle Health Insurance Data Exchange Cloud Service, which is expected to aid long-term growth.
Oracle (ORCL) Launches AI Assistant for Healthcare Providers
by Zacks Equity Research
Oracle (ORCL) announces the general availability of its Clinical Digital Assistant, an AI-powered tool designed to improve patient care in ambulatory clinics across the United States.
Does Oracle's (ORCL) Healthcare Roster Suggest Bright Prospects?
by Zacks Equity Research
Oracle's (ORCL) portfolio of offerings and increased adoption in the healthcare sector are expected to aid top-line growth in the near term.
Are Finance Stocks Lagging Bain Capital Specialty Finance (BCSF) This Year?
by Zacks Equity Research
Here is how Bain Capital Specialty (BCSF) and AllianceBernstein (AB) have performed compared to their sector so far this year.
Zacks Industry Outlook Highlights Bain Capital Specialty Finance, Barings BDC and Crescent Capital
by Zacks Equity Research
Bain Capital Specialty Finance, Barings BDC and Crescent Capital have been highlighted in this Industry Outlook article.
3 SBIC & Commercial Finance Stocks to Buy Amid Grim Industry Prospects
by Swayta Shah
Weak asset quality, high rates and macroeconomic woes are likely to hurt Zacks SBIC & Commercial Finance industry players like Bain Capital (BCSF), Barings BDC (BBDC) and Crescent Capital (CCAP). Yet, decent financing demand across sectors is likely to aid.
Bain Capital Specialty (BCSF) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Bain Capital Specialty (BCSF) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
What's in the Cards for Bain Capital's (BCSF) Q3 Earnings?
by Zacks Equity Research
An increase in total investment income on the back of higher interest rates is expected to have supported Bain Capital's (BCSF) Q3 earnings.
Is Arbor Realty Trust (ABR) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Arbor Realty Trust (ABR) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Bain Capital Specialty (BCSF) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Bain Capital Specialty (BCSF) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Americold Realty Trust (COLD) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Americold Realty Trust Inc. (COLD) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Crescent Capital BDC (CCAP) This Year?
by Zacks Equity Research
Here is how Crescent Capital BDC (CCAP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Is Brookfield Infrastructure Partners (BIP) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Here is how Brookfield Infrastructure Partners (BIP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Are Finance Stocks Lagging Brookfield Infrastructure Partners (BIP) This Year?
by Zacks Equity Research
Here is how Brookfield Infrastructure Partners (BIP) and Bain Capital Specialty (BCSF) have performed compared to their sector so far this year.
Bain Capital Specialty (BCSF) Q4 Earnings Meet Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0% and 7.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Main Street Capital, Bain Capital Specialty Finance and Newtek Business Services
by Zacks Equity Research
Zacks Industry Outlook Highlights: Main Street Capital, Bain Capital Specialty Finance and Newtek Business Services
3 SBIC & Commercial Finance Stocks to Buy Despite Low Rates
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality, and regulatory changes will keep aiding Main Street Capital (GBDC), Bain Capital (BCSF), and Newtek (NEWT).
Bain Capital Specialty (BCSF) Q3 Earnings Match Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0.00% and 9.56%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?
Bain Capital Specialty (BCSF) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Bain Capital Specialty (BCSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bain Capital Specialty (BCSF) Q2 Earnings Match Estimates
by Zacks Equity Research
Bain Capital Specialty (BCSF) delivered earnings and revenue surprises of 0.00% and 1.04%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights: Golub Capital BDC, Bain Capital Specialty Finance and Newtek Business Services Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Golub Capital BDC, Bain Capital Specialty Finance and Newtek Business Services Corp
3 SBIC & Commercial Finance Stocks to Buy Amid Challenges
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality and regulatory changes are likely to aid Golub Capital (GBDC), Bain Capital (BCSF) and Newtek (NEWT).
3 SBIC & Commercial Finance Stocks to Buy Amid Challenges
by Swayta Shah
While lower rates and pre-payments hurt the Zacks SBIC & commercial finance industry players, robust economic growth, impressive asset quality and regulatory changes are likely to aid Golub Capital (GBDC), Bain Capital (BCSF) and Newtek (NEWT).
Gladstone (GAIN) Announces Sale of Head Country Portfolio
by Zacks Equity Research
Gladstone (GAIN) announces sale of portfolio company, Head Country, in turn generating meaningful realized profits on the investment made.
Earnings Preview: Bain Capital Specialty (BCSF) Q4 Earnings Expected to Decline
by Zacks Equity Research
Bain Capital Specialty (BCSF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.